Email this article COVID-19 and the manifestation of psychosis: clinical cases
- Authors: Petrova N.N.1, Manyushina V.M.1
-
Affiliations:
- Saint Petersburg State University
- Issue: Vol LIII, No 4 (2021)
- Pages: 61-69
- Section: Case reports
- URL: https://journals.rcsi.science/1027-4898/article/view/89686
- DOI: https://doi.org/10.17816/nb89686
- ID: 89686
Cite item
Open Access
Access granted
Subscription Access
Abstract
The emergence and global spread of the new coronavirus COVID-19 has placed a significant mental health burden on communities around the world. Many of the mental manifestations of COVID-19 are the result of psychological stressors such as fear of illness and death, prolonged social isolation, insecurity and fear of the future. However, there is growing evidence that the virus itself can cause psychosis in infected people. The potential of the virus to induce psychosis is of particular interest. Much remains to be seen about the biological mechanisms, presentation, treatment and long-term results of psychotic illnesses associated with COVID-19.
METHODS. This article examines cases of manifestation of psychosis against the background of a new coronavirus infection. The features of the development of psychosis, course, response to therapy are analyzed. The analysis of foreign scientific literature on psychoses associated with COVID-19 is carried out.
RESULTS. According to the results of the analysis of clinical cases, acute psychoproductive symptomatology, pronounced anxiety and insomnia were described. A positive response to therapy with second-generation antipsychotics with good tolerance in usual therapeutic dosages was observed in 100% of cases. Achieving a therapeutic response required a change of antipsychotics.
Keywords
Full Text
##article.viewOnOriginalSite##About the authors
Nataliia N. Petrova
Saint Petersburg State University
Author for correspondence.
Email: petrova_nn@mail.ru
ORCID iD: 0000-0003-4096-6208
SPIN-code: 3341-2372
Dr. Sci. (Med.), professor, Head of the Department of Psychiatry and Narcology
Russian Federation, 7/9 Universitetskaya Emb, St.Petersburg, 199034, RussiaVictoria M. Manyushina
Saint Petersburg State University
Email: manushina1996@yandex.ru
ORCID iD: 0000-0001-9678-7589
SPIN-code: 1900-5248
Resident
Russian Federation, 7/9 Universitetskaya Emb, St.Petersburg, 199034, RussiaReferences
- Yahya A.S., Khawaja S., Chukwuma J. The impact of COVID-19 in psychiatry. Prim. Care Companion CNS Disord. 2020; 22 (2): 20102627. doi: 10.4088/PCC.20l02627.
- Galletly С. Psychiatry in the COVID-19 era. Australian & New Zealand Journal of Psychiatry. 2020; 54 (5): 447–448. doi: 10.1177/0004867420920359.
- Chacko М., Job А., Caston F. et al. COVID-19-induced psychosis and suicidal behavior: Case report. SN Comprehensive Clinical Medicine. 2020; 2: 2391–2395.
- Varatharaj A., Thomas N., Ellul M.A. et al. Neurological and neuropsychiatric complications of COVID-19 in 153 patients: a UK-wide surveillance study. Lancet Psychiatry. 2020; 7 (10): 875–882. doi: 10.1016/S2215-0366(20)30287-X.
- Rogers J.P., Chesney E., Oliver D. et al. Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: a systematic review and meta-analysis with comparison to the COVID-19 pandemic. Lancet Psychiatry. 2020; 7 (7): 611–627. doi: 10.1016/S2215-0366(20)30203-0.
- Petrova N.N., Pashkovskii V.E., Sivashova M.S. et al. Vliyanie psikhicheskikh rasstroistv na iskhod COVID-19. Nevrologiya, neiropsikhiatriya, psikhosomatika. 2021; 13 (5): 40–47. doi: 10.14412/2074-2711-2021-5-40-47.
- Vai B., Mazza M.G., Delli Colli C. et al. Mental disorders and risk of COVID-19-related mortality, hospitalisation, and intensive care unit admission: a systematic review and meta-analysis. Lancet Psychiatry. 2021; 8 (9): 797–812. doi: 10.1016/S2215-0366(21)00232-7.
- Mazza M.G., De Lorenzo R., Conte C. et al. Anxiety and depression in COVID-19 survivors: Role of inflammatory and clinical predictors. Brain Behavю Immun. 2020; 89: 594–600. doi: 10.1016/j.bbi.2020.07.037.
- Taquet M., Geddes J.R., Husain M. et al. 6-month neurological and psychiatric outcomes in 236,379 survivors of COVID-19: A retrospective cohort study using electronic health records. The Lancet Psychiatry. 2021; 8 (5): 416–427.
- Valdes-Florido M.J., Lopez-Diaz A., Palermo-Zeballos F.J. et al. Clinical characterization of brief sychotic disorders triggered by the COVID-19 pandemic: A multicenter observational study. Eur. Arch. Psychiatry Clin. Neurosci. 2021; 1–11. doi: 10.1007/s00406-021-01256-w.
- Belvederi Murri M., Zotos S., Cantarelli L. et al. Between China and Italy: A case report of first-episode schizophrenia in the Covid-19 era. Psychiatry Research. 2021; 298: 113804. doi: 10.1016/j.psych.res.2021.113804.
- Jagadheesan K., Danivas V., Itrat Q. et al. A 6-month study on the pattern of emergency department presentations for schizophrenia and other psychotic disorders during COVID-19 lockdown. Psychiatry Research. 2021; 303: 114081. doi: 10.1016/j.psych.res.2021.114081.
- McCutcheon R.A., Reis Marques T., Howes O.D. Schizophrenia — An overview. JAMA Psychiatry. 2020; 77 (2): 201–210. doi: 10.1001/jamapsychiatry.2019.3360.
- Oloniniyi I.O., Ibigbami O.I., Amiola A. et al. First episode psychosis during COVID-19 pandemic: A case series. West African Journal of Medicine. 2021; 38 (6): 599–603.
- Hu W., Su L., Li D. et al. Risk of first-episode schizophrenia in aged adults increased during COVID-19 Outbreak. International Journal of Mental Health and Addiction. 2021. Р. 1–11. doi: 10.1007/s11469-021-00671-3.
- Robinson-Agramonte М., Gonçalves C.-A., Noris-García Е. Impact of SARS-CoV-2 on neuropsychiatric disorders. World J. Psychiatry. 2021; 11 (7): 347–354. doi: 10.5498/wjp.v11.i7.347.
- Smith С.М., Komisar J.R., Mourad A., Kincaid B.R. COVID-19-associatedbrief psychotic disorder. BMJ Case Rep. 2020; 13 (8): e236940. doi: 10.1136/bcr-2020-236940.
- Mendelevich V.D., Mullina N.B. Sluchai ostroi gipomanii pri COVID-19: povinen li koronavirus? Psikhiatriya i psikhofarmakoterapiya. 2020; 5: 51–54.
- Kozato N., Mishra М., Firdosi М. New-onset psychosis due to COVID-19. BMJ Case Rep. 2021; 14 (4): e242538. doi: 10.1136/bcr-2021-242538.
- Ferrando S.J., Klepacz L., Lynch S. et al. COVID-19 psychosis: A potential new neuropsychiatric condition triggered by novel coronavirus infection and the inflammatory response? Psychosomatics. 2020; 61 (5): 551–555. doi: 10.1016/j.psym.2020.05.012.
